Light therapy for abnormal cervical or vaginal cells
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a light-based treatment (photodynamic therapy) for high-grade or persistent low-grade abnormal cells in the cervix or vagina. It aims to destroy these cells without surgery, which may be an option for patients who want to avoid more invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high-grade abnormal cells in the cervix (CIN2 or CIN3) or vagina (VaIN2 or VaIN3), confirmed by a biopsy.
- Or you have low-grade abnormal cells (CIN1 or VaIN1) that have lasted more than one year and you want treatment.
- Your doctor was able to see the area clearly during a colposcopy exam.
- A sample from your cervical canal did not show any higher-grade abnormal cells.
- You do not have cancer or any suspicion of cancer.
- You do not have porphyria (a blood disorder) or a known allergy to red or blue light.
- You do not have other serious medical conditions that could interfere with the treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a light-based treatment called photodynamic therapy for women with moderate to severe cervical changes (CIN3). It aims to destroy abnormal cells while saving healthy tissue.
This study tests a light-based treatment called photodynamic therapy for cervical pre-cancer (CIN2). It may help remove abnormal cells while avoiding more invasive surgery, and aims to see if this treatment is safe and works well.
This study tests a light-based treatment called ALA-PDT to see if it can help clear precancerous cervical changes caused by HPV types 16 or 18. It may be an option to avoid more invasive procedures.
This trial tests a light-based treatment (photodynamic therapy) for high-grade cervical precancerous changes, which may avoid the need for immediate surgery. It compares this approach to standard surgery to see if it is safe and effective.
This trial tests a light-activated therapy (called HAL-PDT) for a specific type of abnormal cervical cell change known as CIN2. It aims to see if this treatment can destroy the abnormal cells while keeping the cervix healthy, potentially avoiding surgery.
This study compares two treatments—photodynamic therapy using a special light-activated cream and a CO2 laser—to see which works better for clearing low-grade cervical changes caused by a long-lasting high-risk HPV infection. The goal is to find a safe, effective option for women who have had this condition for over a year.
Hear when a new Precancerous Cervical Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.